Abstract

Viral cirrhosis is a chronic liver disease caused by viral infections and is associated with numerous systemic complications. One such complication is metabolic bone disease, characterized by reduced bone mineral density and increased risk of fractures. This prospective analysis aims to investigate the prevalence, risk factors, and impact of metabolic bone disease in patients with viral cirrhosis. By conducting a longitudinal study, we hope to shed light on the complex interplay between liver dysfunction and bone health, providing valuable insights into preventive measures and potential therapeutic interventions.